Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)  
$30.61 0.21 (0.68%) as of 4:30 Mon 5/20


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 49,450,000
Market Cap: 1.51(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $25.5 - $41.52
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  623
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 119,323 119,323 189,781 290,198
Total Sell Value $3,656,226 $3,656,226 $6,334,261 $12,063,571
Total People Sold 1 1 15 16
Total Sell Transactions 3 3 34 58
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 781
  Page 12 of 32  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Stack David M CEO and Chairman   •       •      –    2020-06-08 4 S $48.08 $823,402 D/D (17,111) 166,909 -13%     
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-06-05 4 S $48.37 $84,744 D/D (1,752) 7,833 -15%     
   Dunker Kristen Marie Chief Administrative Officer   •       –      –    2020-06-05 4 S $48.61 $286,993 D/D (5,904) 10,887 -15%     
   Brege Laura Director   –       •      –    2020-06-05 4 S $48.70 $102,270 D/D (2,100) 6,661 -15%     
   Hastings Paul J Director   –       •      –    2020-06-04 4 S $47.46 $96,107 D/D (2,025) 4,856 -24%     
   Mcloughlin Dennis Chief Commercial Officer   •       –      –    2020-06-04 4 S $46.33 $67,041 D/D (1,447) 14,898 -24%     
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-06-04 4 S $46.33 $40,725 D/D (879) 9,585 -24%     
   Reinhart Charles A. Iii Chief Financial Officer   •       –      –    2020-06-04 4 S $46.33 $68,987 D/D (1,489) 14,847 -24%     
   Dunker Kristen Marie Chief Administrative Officer   •       –      –    2020-06-04 4 S $46.33 $111,287 D/D (2,402) 16,791 -24%     
   Stack David M CEO and Chairman   •       •      –    2020-06-04 4 S $46.33 $663,182 D/D (14,314) 184,020 -24%     
   Laranjeira Charles Anthony SVP, Technical Operations   •       –      –    2020-06-04 4 S $46.33 $39,984 D/D (863) 10,101 -24%     
   Manning Donald C. Chief Medical Officer   •       –      –    2020-06-02 4 A $0.00 $0 D/D 28,500 28,500     -
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-05-21 4 S $45.26 $90,520 D/D (2,000) 10,464 -32%     
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-05-21 4 OE $10.34 $20,680 D/D 2,000 12,464     -
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-05-19 4 S $42.81 $85,620 D/D (2,000) 10,464 -47%     
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-05-19 4 OE $10.34 $20,680 D/D 2,000 12,464     -
   Longenecker John P Phd Director   –       •      –    2020-03-12 4 OE $1.61 $6,015 D/D 3,736 16,497     -
   Pace Gary W Director   –       •      –    2020-03-12 4 OE $1.61 $96,845 D/D 21,736 58,689     -
   Winston Roy Chief Clinical Officer   •       –      –    2020-03-11 4 B $36.50 $91,250 D/D 2,500 25,237 2.74 56%     
   Stack David M CEO and Chairman   •       •      –    2020-02-21 4 OE $1.61 $121,189 D/D 35,856 198,334     -
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-02-10 4 AS $47.81 $146,430 D/D (3,000) 10,464 -5%     
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-02-10 4 OE $10.81 $32,430 D/D 3,000 13,464     -
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-02-07 4 AS $46.81 $7,958 D/D (170) 10,464 -6%     
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-02-07 4 OE $10.81 $1,838 D/D 170 10,634     -
   Riker Lauren Bullaro Vice President, Finance   •       –      –    2020-02-06 4 AS $46.81 $38,852 D/D (830) 10,464 2%     
  781 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 12 of 32
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us